Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Plitas

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Nature Communications|September 9, 2020
Enhancing mucosal immunity by transient microbiota depletionSimone Becattini, Eric R Littmann, Ruth Seok, et al.
NPJ Breast Cancer|March 4, 2026
Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancerAntonio Marra, Sarah H Kim, Fresia Pareja, et al.
Annals of Surgical Oncology|August 1, 2020
Changing the Default: A Prospective Study of Reducing Discharge Opioid Prescription after Lumpectomy and Sentinel Node BiopsyTracy-Ann Moo, Kate R Pawloski, Varadan Sevilimedu, et al.
British Journal of Anaesthesia|November 22, 2020
Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancerGiacomo Montagna, Hersh V Gupta, Margaret Hannum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2011
Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosisSteven C Katz, Kristin Ryan, Naseem Ahmed, et al.
NPJ Breast Cancer|October 2, 2025
Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancerNour Abuhadra, Fresia Pareja, Charlie White, et al.
Annals of Surgical Oncology|December 11, 2019
Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible PatientsAndrea V Barrio, Stephanie Downs-Canner, Marcia Edelweiss, et al.
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
Annals of Surgical Oncology|May 11, 2016
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective StudyAnita Mamtani, Andrea V Barrio, Tari A King, et al.
Annals of Surgical Oncology|August 27, 2013
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapyLynn T Dengel, Kimberly J Van Zee, Tari A King, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Nature Communications|September 9, 2020
Enhancing mucosal immunity by transient microbiota depletionSimone Becattini, Eric R Littmann, Ruth Seok, et al.
NPJ Breast Cancer|March 4, 2026
Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancerAntonio Marra, Sarah H Kim, Fresia Pareja, et al.
Annals of Surgical Oncology|August 1, 2020
Changing the Default: A Prospective Study of Reducing Discharge Opioid Prescription after Lumpectomy and Sentinel Node BiopsyTracy-Ann Moo, Kate R Pawloski, Varadan Sevilimedu, et al.
British Journal of Anaesthesia|November 22, 2020
Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancerGiacomo Montagna, Hersh V Gupta, Margaret Hannum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2011
Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosisSteven C Katz, Kristin Ryan, Naseem Ahmed, et al.
NPJ Breast Cancer|October 2, 2025
Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancerNour Abuhadra, Fresia Pareja, Charlie White, et al.
Annals of Surgical Oncology|December 11, 2019
Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible PatientsAndrea V Barrio, Stephanie Downs-Canner, Marcia Edelweiss, et al.
Iscience|February 9, 2024
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancerElizabeth Comen, Sadna Budhu, Yuval Elhanati, et al.
Annals of Surgical Oncology|May 11, 2016
How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective StudyAnita Mamtani, Andrea V Barrio, Tari A King, et al.
Annals of Surgical Oncology|August 27, 2013
Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapyLynn T Dengel, Kimberly J Van Zee, Tari A King, et al.
Pageof 7